Cycad Group - Xconomy

by in

Entry	Author	Date	Location
Adimab, ImmunoGen, OvaScience, & More Boston Life Sciences News	Erin Kutz	04/06/12	Boston
OvaScience Adds $37M for Fertility Treatments	Arlene Weintraub	04/04/12	Boston
OvaScience Lands $37,000,000 Series B Financing	VentureDeal	04/04/12	Boston
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News	Erin Kutz	01/07/11	Boston
SCVNGR Scares Up $15M, Genocea Gets $35M, Zeo Zeros in on $12.3M, & More Boston-Area Deals News	Rebecca Zacks	01/05/11	Boston
Genocea Biosciences Raises $35M from J&J and Others for Vaccines Business	Ryan McBride	01/03/11	Boston
Genocea Biosciences Obtains $35,000,000 Series B Funding Round	VentureDeal	01/03/11	Boston
NanoSteel Reports $8M Round	Ryan McBride	08/21/09	Boston
NanoSteel Company Garners $8,000,000 New Financing Round	VentureDeal	08/21/09	Boston
Alnylam’s Spinoff Strategy, Genzyme’s Gaucher-Business Future, Adimab’s Antibody Ambitions, & More Boston-Area Life Sciences News	Rebecca Zacks	02/25/09	Boston
Vertex’s $320M SPO, Verenium and BP’s Joint Venture, Genocea’s $23M Series A, & More Boston-Area Deals News	Rebecca Zacks	02/20/09	Boston
Genocea Biosciences Receives $23,000,000 Series A Financing Round	VentureDeal	02/19/09	Boston
Page 1 of 1